These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35604094)

  • 1. Structure-Guided Synthesis of FK506 and FK520 Analogs with Increased Selectivity Exhibit
    Hoy MJ; Park E; Lee H; Lim WY; Cole DC; DeBouver ND; Bobay BG; Pierce PG; Fox D; Ciofani M; Juvvadi PR; Steinbach W; Hong J; Heitman J
    mBio; 2022 Jun; 13(3):e0104922. PubMed ID: 35604094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging Fungal and Human Calcineurin-Inhibitor Structures, Biophysical Data, and Dynamics To Design Selective and Nonimmunosuppressive FK506 Analogs.
    Gobeil SM; Bobay BG; Juvvadi PR; Cole DC; Heitman J; Steinbach WJ; Venters RA; Spicer LD
    mBio; 2021 Dec; 12(6):e0300021. PubMed ID: 34809463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents.
    Juvvadi PR; Fox D; Bobay BG; Hoy MJ; Gobeil SMC; Venters RA; Chang Z; Lin JJ; Averette AF; Cole DC; Barrington BC; Wheaton JD; Ciofani M; Trzoss M; Li X; Lee SC; Chen YL; Mutz M; Spicer LD; Schumacher MA; Heitman J; Steinbach WJ
    Nat Commun; 2019 Sep; 10(1):4275. PubMed ID: 31537789
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Lee Y; Lee KT; Lee SJ; Beom JY; Hwangbo A; Jung JA; Song MC; Yoo YJ; Kang SH; Averette AF; Heitman J; Yoon YJ; Cheong E; Bahn YS
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FKBP12-Dependent Inhibition of Calcineurin Mediates Immunosuppressive Antifungal Drug Action in
    Ianiri G; Applen Clancey S; Lee SC; Heitman J
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-guided design and synthesis of C22- and C32-modified FK520 analogs with enhanced activity against human pathogenic fungi.
    Dome PA; Jeong P; Nam G; Jang H; Rivera A; Averette AF; Park E; Liao TC; Ciofani M; Wu J; Chi JA; Venters RA; Park HJ; Steinbach WJ; Juvvadi PR; Heitman J; Hong J
    bioRxiv; 2024 Nov; ():. PubMed ID: 39386510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced fungal specificity and
    Rivera A; Lim WY; Park E; Dome PA; Hoy MJ; Spasojevic I; Sun S; Averette AF; Pina-Oviedo S; Juvvadi PR; Steinbach WJ; Ciofani M; Hong J; Heitman J
    bioRxiv; 2023 Jul; ():. PubMed ID: 37333270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein.
    Odom A; Del Poeta M; Perfect J; Heitman J
    Antimicrob Agents Chemother; 1997 Jan; 41(1):156-61. PubMed ID: 8980772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans.
    Del Poeta M; Cruz MC; Cardenas ME; Perfect JR; Heitman J
    Antimicrob Agents Chemother; 2000 Mar; 44(3):739-46. PubMed ID: 10681348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans.
    Arndt C; Cruz MC; Cardenas ME; Heitman J
    Microbiology (Reading); 1999 Aug; 145 ( Pt 8)():1989-2000. PubMed ID: 10463165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthesis of Nonimmunosuppressive FK506 Analogues with Antifungal Activity.
    Beom JY; Jung JA; Lee KT; Hwangbo A; Song MC; Lee Y; Lee SJ; Oh JH; Ha SJ; Nam SJ; Cheong E; Bahn YS; Yoon YJ
    J Nat Prod; 2019 Aug; 82(8):2078-2086. PubMed ID: 31321978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin regulatory subunit is essential for virulence and mediates interactions with FKBP12-FK506 in Cryptococcus neoformans.
    Fox DS; Cruz MC; Sia RA; Ke H; Cox GM; Cardenas ME; Heitman J
    Mol Microbiol; 2001 Feb; 39(4):835-49. PubMed ID: 11251806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FKBP12 dimerization mutations effect FK506 binding and differentially alter calcineurin inhibition in the human pathogen Aspergillus fumigatus.
    Juvvadi PR; Bobay BG; Gobeil SMC; Cole DC; Venters RA; Heitman J; Spicer LD; Steinbach WJ
    Biochem Biophys Res Commun; 2020 May; 526(1):48-54. PubMed ID: 32192767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A calcineurin antifungal strategy with analogs of FK506.
    Nambu M; Covel JA; Kapoor M; Li X; Moloney MK; Numa MM; Soltow QA; Trzoss M; Webb P; Webb RR; Mutz M
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2465-2471. PubMed ID: 28412204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the FKBP12-Encoding Genes in Aspergillus fumigatus.
    Falloon K; Juvvadi PR; Richards AD; Vargas-Muñiz JM; Renshaw H; Steinbach WJ
    PLoS One; 2015; 10(9):e0137869. PubMed ID: 26366742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach.
    Juvvadi PR; Lee SC; Heitman J; Steinbach WJ
    Virulence; 2017 Feb; 8(2):186-197. PubMed ID: 27325145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei.
    Onyewu C; Blankenship JR; Del Poeta M; Heitman J
    Antimicrob Agents Chemother; 2003 Mar; 47(3):956-64. PubMed ID: 12604527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR.
    Cruz MC; Goldstein AL; Blankenship J; Del Poeta M; Perfect JR; McCusker JH; Bennani YL; Cardenas ME; Heitman J
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3162-70. PubMed ID: 11600372
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Gobeil SMC; Bobay BG; Spicer LD; Venters RA
    Biomol NMR Assign; 2019 Apr; 13(1):207-212. PubMed ID: 30707421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically engineered analogs of ascomycin for nerve regeneration.
    Revill WP; Voda J; Reeves CR; Chung L; Schirmer A; Ashley G; Carney JR; Fardis M; Carreras CW; Zhou Y; Feng L; Tucker E; Robinson D; Gold BG
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1278-85. PubMed ID: 12183690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.